Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland · Delayed Price · Currency is CHF 9.06
+0.06 (0.67%)
Nov 12, 2026, 1:12 PM CET
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of 192.42 million as of November 11, 2026. It is the 19,704th most valuable company in the world and the 167th biggest in Switzerland. Its market cap has decreased by 32.49% in one year.
Market Cap
192.42M
Enterprise Value
198.10M
Revenue
9.62M
Global Rank
Country Rank
#167 Switzerland
PE Ratio
n/a
ChartMarket Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 309.05M to 192.42M, a decrease of -37.74%. That is a compound annual growth rate of -2.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 192.42M | -59.58% |
| Dec 30, 2025 | 476.07M | 173.36% |
| Dec 30, 2024 | 174.16M | 97.16% |
| Dec 29, 2023 | 88.33M | 219.35% |
| Dec 30, 2022 | 27.66M | -4.32% |
| Dec 30, 2021 | 28.91M | -24.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 6.00B |
| Idorsia | 1.12B |
| Basilea Pharmaceutica AG | 897.16M |
| Santhera Pharmaceuticals Holding AG | 232.67M |
| BioVersys AG | 131.97M |
| Molecular Partners AG | 98.91M |
| Xlife Sciences AG | 49.60M |
| MindMaze Therapeutics Holding | 23.02M |